Your Location:
Home >
Browse articles >
Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study
RESEARCH | Updated:2026-06-10
Identification of the lymph node metastasis atlas and optimal lymph node dissection strategy in patients with resectable lung invasive mucinous adenocarcinoma: a real-world multicenter study
- “A multicenter study of 1,474 LIMA patients reveals distinct lymph node metastasis patterns, with stations 14 and 10 most commonly affected. Researchers established a risk-stratified dissection strategy, identifying 6-20 nodes as optimal and 18 as the key cutoff for uncertain cases, balancing accurate staging with long-term prognosis preservation.”
- Military Medical Research Vol. 13, Issue 5, Pages: 689-705(2026)
DOI: 10.1186/s40779-025-00659-3
Accepted:02 October 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 5 ) Tabs( 0 )
References
Publication Info
Metrics
43
Views
35
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Exosome autoantibody biomarkers for detection of lung cancer
China stroke surveillance report 2021
Establishment and effectiveness evaluation of a scoring system for exertional heat stroke by retrospective analysis
Relationship between expression of cathepsin D and proliferating cell nuclear antigen and prognosis in osteosarcoma
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Related Author
Nurul Huda Rutt
Win Lwin Thuya
Janique Michelle Peyper
Tan Ti Myen
Nur Diana Anuar
Arif Anwar
Boon Cher Goh
Ling-Zhi Wang
Related Institution
Department of Haematology-Oncology, National University Cancer Institute, National 17 University Health System
Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 15 1E Kent Ridge Road
NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore
Cancer Science Institute of Singapore, National University of Singapore

